Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits2 as of December 31, 2025Revenues of €4.5…
February 13, 2026 16:30 ET | Source: Natural Alternatives International Inc CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural…
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase…
50-year study of the US market and 20 years of foreign market data informs components of market value.NEW YORK, Feb.…
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and…
Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public…
Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net…
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided statistically significant and clinically meaningful reductions in annualized…
BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed…
Shipments Increase in 2025 Amid Strong AI-driven Demand, While Revenue SoftensMILPITAS, Calif., Feb. 10, 2026 /PRNewswire/ -- Worldwide silicon wafer…